Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3 East Qingchun Road, Hangzhou, Zhejiang 310016, China.
School of Medicine, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang 310058, China.
Can J Gastroenterol Hepatol. 2018 Mar 1;2018:1746895. doi: 10.1155/2018/1746895. eCollection 2018.
To present a meta-analysis of high-quality case-matched studies comparing laparoscopic (LH) and open hepatectomy (OH) for hepatocellular carcinoma (HCC).
Studies published up to September 2017 comparing LH and OH for HCC were identified. Selection of high-quality, nonrandomized comparative studies (NRCTs) with case-matched design was based on a validated tool (Methodological Index for Nonrandomized Studies) since no randomized controlled trials (RCTs) were published. Morbidity, mortality, operation time, blood loss, hospital stay, margin distance, recurrence, and survival outcomes were compared. Subgroup analyses were carried out according to the surgical extension (minor or major hepatectomy).
Twenty studies with a total of 830 patients (388 in LH and 442 in OH) were identified. For short-term surgical outcomes, LH showed less morbidity (RR = 0.55; 95% CI, 0.470.65; < 0.01), less mortality (RR = 0.43; 95% CI, 0.181.00; = 0.05), less blood loss (WMD = -93.21 ml, 95% CI, -157.33-29.09 ml; < 0.01), shorter hospital stay (WMD = -2.86, 95% CI, -3.63-2.08; < 0.01), and comparable operation time (WMD = 9.15 min; 95% CI: -7.6125.90, = 0.28). As to oncological outcomes, 5-year overall survival rate was slightly better in LH than OH (HR = 0.66, 95% CI: 0.520.84, < 0.01), whereas the 5-year disease-free survival rate was comparable between two groups (HR = 0.88, 95% CI: 0.74~1.06, = 0.18).
This meta-analysis has highlighted that LH can be safely performed in selective patients and improves surgical outcomes as compared to OH. Given the limitations of study design, especially the limited cases of major hepatectomy, methodologically high-quality comparative studies are needed for further evaluation.
对腹腔镜(LH)与开腹肝切除术(OH)治疗肝细胞癌(HCC)的高质量病例匹配研究进行荟萃分析。
检索截至 2017 年 9 月比较 LH 和 OH 治疗 HCC 的研究。选择基于验证工具(非随机研究方法学指数)的高质量、非随机对照研究(NRCT),采用病例匹配设计,因为没有发表随机对照试验(RCT)。比较发病率、死亡率、手术时间、出血量、住院时间、切缘距离、复发和生存结果。根据手术范围(小或大肝切除术)进行亚组分析。
共确定了 20 项研究,共计 830 例患者(LH 组 388 例,OH 组 442 例)。短期手术结果显示,LH 的发病率较低(RR=0.55;95%CI,0.470.65;<0.01),死亡率较低(RR=0.43;95%CI,0.181.00;=0.05),出血量较少(WMD=-93.21ml;95%CI,-157.33-29.09ml;<0.01),住院时间较短(WMD=-2.86;95%CI,-3.63-2.08;<0.01),手术时间相当(WMD=9.15min;95%CI:-7.6125.90;=0.28)。至于肿瘤学结果,LH 组 5 年总生存率略高于 OH 组(HR=0.66;95%CI:0.520.84;<0.01),而两组 5 年无病生存率相当(HR=0.88;95%CI:0.74~1.06;=0.18)。
本荟萃分析强调,LH 可安全用于选择性患者,并改善手术结果,优于 OH。鉴于研究设计的局限性,特别是大肝切除术的病例有限,需要进一步评估方法学上高质量的对照研究。